Directory · LT
Biotechnology Research in Lithuania
A register of firms and the professionals working at them in the Biotechnology Research sector based in Lithuania. Browse the public index, then filter or export on Kipplo.
Companies
63 on file
Atrandi Biosciences
Atrandi Biosciences, founded in 2016, is a pioneering life sciences tool company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology. This next-generation technology isolates tens of thousands of single cells within discrete, permeable compartments, allowing bulk reactions to proceed as usual while preserving single-cell resolution. SPCs have already unlocked previously inaccessible applications, such as high-throughput microbial and eukaryotic genomics, and are poised to enable true single-cell multiomics. Headquartered in Vilnius, Lithuania, Atrandi’s name, meaning “you discover” in Lithuanian, embodies the company’s mission to empower scientists to uncover the unknown and make groundbreaking discoveries.
51 to 200 staff
Nando
Nando" is a biotechnology company that develops and manufactures high-added-value microbiological products and chemical additives for agriculture and industry. Through innovation, combining scientific advances in biotechnology, chemistry and engineering, the company develops and markets biostimulants, surfactants and chemical products for use in crop and livestock production and in various industries. With one of the largest R&D (research and experimental development) centers in Northern Europe, and in collaboration with research centers and universities worldwide, “Nando“ has developed a portfolio of over 50 specialized products
51 to 200 staff
Biomatter
Biomatter (previously called Biomatter Designs) is a synthetic biology company that creates new proteins for health and sustainable manufacturing applications. The company has developed the Intelligent Architecture™ platform that addresses limitations of current engineering approaches to unlock completely new horizons for protein design and development.
11 to 50 staff
Inospectra
Inospectra supplies laboratory and analytical equipment. We represent world’s famous high-quality laboratory equipment manufacturers. Our customers are scientists, researchers and quality control specialists. Inospectra team members constantly upgrade their skills by participating in manufacturer trainings in various scientific exhibitions and conferences in order to ensure high-quality customer service and prompt repair services. Inospectra seeks to meet their customer expectations and deliver high-quality products and services not only for Lithuania, but also in other Baltic countries. We always pay attention of our customer feedback in order to improve the quality of services. Company is using an integrated quality and environmental management system in compliance with the international standards ISO 9001 and ISO 14001. All supplied Inospectra products have Lithuanian and the European Union required certificates and are made with the highest quality requirements. Company's Greatest Assets - customers, professionalism, orientation towards long-term goal, responsibility, respect and innovations.
1 to 10 staff
Roche Lietuva
Šveicarijos kompanija „Roche“ yra viena didžiausių biotechnologijų bendrovių pasaulyje, kurianti vaistus ir diagnostikos priemones onkologinėms, virusų sukeltoms, uždegiminėms, centrinės nervų sistemos ligoms gydyti. Bendrovės sveikatos priežiūros strategija pagrįsta individualizuotu požiūriu į kiekvieną pacientą. Šie sprendimai reikšmingai pagerina pacientų sveikatą, gyvenimo kokybę ir prailgina jų gyvenimo trukmę. Kompanija „Roche“ įkurta 1896 m. ir jau daugiau nei šimtą metų prisideda prie žmonių sveikatos gerinimo visame pasaulyje. Net 30 bendrovės sukurtų medikamentų yra įtraukti į Pasaulio sveikatos organizacijos būtinųjų vaistų sąrašą. Vienuoliktus metus iš eilės „Roche“ pripažįstama kaip farmacijos, biotechnologijos ir biomedicinos mokslų pramonės lyderė pagal Dou Džonso (angl. Dow Jones) tvarumo indeksą. Be pagrindinės veiklos, bendrovė daug dėmesio skiria filantropinei veiklai: nuo pat įkūrimo „Roche“ nuolat remia mokslo ir socialinius projektus bei kultūrines iniciatyvas. „Roche“ padaliniuose visame pasaulyje 2020 m. dirbo daugiau nei 100 darbuotojų, o į tyrimų ir vystymo programas buvo investuota 12,2 milijardo Šveicarijos frankų. Įmonių grupės apyvarta siekė 58,3 milijardo Šveicarijos frankų. Norėdami sužinoti daugiau apie mūsų bendrovę, apsilankykite: #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
51 to 200 staff
Bioversio
Bioversio is a biotechnology company, a developer and manufacturer of biological products for agriculture.
1 to 10 staff
Biotecha
BIOTECHA provides engineering and bioprocess solutions that help pharma and biotech companies run reliable, efficient, and compliant operations. With nearly 20 years of experience, we deliver cleanrooms, process systems, water purification, laboratory installations, and consumables. Under INTO Bioprocess, we represent custom single-use assemblies and bags. We focus on precise engineering, dependable execution, and solutions that keep your processes running.
51 to 200 staff
Caszyme
At CASZYME, we provide CRISPR Solutions. Differently. We are trusted innovators propelling CRISPR technology and working closely in partnership with our diverse clients to develop dynamic, customized solutions that tackle complex challenges in healthcare and sustainability. Our core values are being Courageous, Curious, Collaborative, Caring, Committed to Change. Daring to be Different and deep passion for work are our guiding principles. We recognize that boldness is key to driving change, and we take pride in pursuing our unique path while cherishing our values.
11 to 50 staff
Innovative Medicine Centre
At the Centre for Innovative Medicine (IMCentras), we’re dedicated to turning scientific discoveries into real-world medical solutions. Based in Vilnius, Lithuania, we bring together researchers, healthcare innovators, and industry partners to drive progress in medicine and biotechnology. What we do: Regenerative Medicine – Developing stem cell therapies and new approaches to tissue repair. 🧬 Immunology & Neuroscience – Studying the immune system and nervous system to better understand diseases. 🩺 Personalized Medicine – Creating tailored treatments and diagnostics for individual patients. Preclinical & In Vivo Research – Providing biomodels and research services for drug development. Genetic & Cellular Engineering – Exploring new technologies to advance biomedical science. Looking to collaborate or learn more? Visit or reach out at imc@imcentras.lt.
51 to 200 staff
Wellgem Biopharma
Contract development, testing and manufacturing of biologics Services are as follows: Biologics development and manufacturing Biologics testing and release Quality services for biologics Pre-clinical pilot scale manufacturing Consulting services on biologics proceses, facilities design, quality and business cases
11 to 50 staff
Integral Solutions
Integral Solutions is an advanced biotechnological startup specializing in the cultivation and application of microbiome-centric solutions. Our cutting-edge research and development are geared towards amplifying cognitive resilience under high-stress conditions, catering to military, aerospace, and athletic sectors. Our central mission is to pioneer health and performance enhancements through sophisticated microbiome optimization. Contact us to learn more.
1 to 10 staff
Vilnius University, Life Sciences Center
The history of Vilnius University Life Sciences Center starts in March 2016 after official opening ceremony. The Center has strengthened research, studies and technological advance in the fields of biochemistry, biotechnology, molecular biology, genetics, neurobiology, molecular medicine and related areas.
201 to 500 staff
Biogroup Baltics
Our mission is to bring life science solutions to the people. To pursue it, we unite companies operating in different business sectors: Sales & Distribution, Engineering Design, Production, Retail, and E-Commerce. We ensure a presence in Baltics' local entities through companies: • Biotecha – industrial and laboratory equipment supply. • Bioprocess Solutions – single-use systems and products for biotechnology. • Biomedika – technologically advanced medical devices distribution. • Biomedikos centras – innovative healthcare products retail. Our values rely on the environment and the community. Commitment and attention to every individual help us build trust within our employees and keep strong relations with partners. We support personal and business development by fostering a healthy work environment, investing in renewable energy sources, and creating value through collaborative projects.
51 to 200 staff
Biosyyd
Biosyyd is committed to a future of health and wellness, providing the absolute best in industrial hemp products. It all starts with a selection of EU-certified genetics, cultivating at GLOBALG.A.P. certified standards. We implemented the Food Safety Management System according to the requirements of ISO and HACCP. In addition, we comply with and produce under a traceable and transparent set of EU Cosmetic GMP (ISO 22716:2007), and EU Pharmaceutical GMP (Active Pharmaceutical Ingredients), and just recently, we were certified with ISO 9001:2015, which reflects our dedication to maintaining the highest standards and efficiency, as well as our commitment to customer satisfaction, process improvement, and regulatory compliance. We are a rapidly growing team of hemp growers, technical engineers, chemists, botanists, economists, and quality control specialists. We are focused on the research and applicability of natural herbal remedies to cosmetics, supplements, functional food, and more. We are actively working on preclinical research and development of cannabinoids as a promising novel treatment strategy targeting numerous diseases affecting human health. By using state of art techniques as well as by collaborating with research institutions worldwide, we are developing novel antimicrobial, cytostatic, and anti-inflammatory products that are currently being investigated in the preclinical research and development pipeline. Recent studies demonstrating antimicrobial activity were presented at the international ASM Microbe 2022 conference in Washington DC, USA, and ESCMID/ASM 2022 Conference on Drug Development in Dublin, Ireland.
11 to 50 staff
Laborama
Laborama is a supplier of advanced technologies for diagnostics and science in the Baltic region. Laborama was established in 2017. It developed from the Science and Laboratory Research Technology unit of the parent company Interlux Interlux Group is an international company together with its subsidiaries providing innovative, top-quality technologies and solutions for medicine, science and biotechnology industry to the customers of the Baltic region, who trust Interlux for almost quarter of a century (24 years). Laborama implements innovative solutions in Flow Cytometry, Cell Biology, Industrial and Clinical Microbiology, Molecular Biology. An innovative company also supplies variety of devices and accessories to researchers and advanced laboratory technology users. One of our new outstanding business niche is a DNA based genetic research services, such as drug tolerance DNA testing, cancer genetic research, prenatal testing and other DNA testing We represent high-end diagnostics and laboratory research technologies manufacturers such as BD, MDX Health, Mettler-Toledo Rainin, Qiagen, NanoString, Corning, Immucor, AutoGenomics, Lonza, Miltenyi Biotec and other advanced technology providers for diagnostics and science. We ensure not only timely delivery and smooth introduction of innovative high quality, certified, environmentally friendly products, but also provide customer training, application support and professional 24/7 technical service and maintenance. The Laborama team is committed to provide each customer with a solution that suits the most specific needs of the laboratory and is ready to solve any issues that you have to deal with quickly.
11 to 50 staff
Vital3d Technologies
Vital3D Technologies is a leading provider of laser-based 3D bioprinting solutions for the production of functional human organs. Our innovative technology uses lasers to precisely deposit living cells and biomaterials in 3D patterns, allowing us to create functional, scalable, and reproducible tissue constructs. Our focus is on developing 3D bio-printed kidneys, which have the potential to revolutionize the treatment of kidney disease and other related conditions. By partnering with leading researchers and medical institutions, we aim to bring our cutting-edge technology to the forefront of the bioprinting industry and make a meaningful impact on patient care.
1 to 10 staff
Pentasweet
Pentasweet is a biotechnology company pioneering a next-generation, high intensity protein sweetener Brazzein that is 1,500x sweeter than sugar. Founded in 2023 and headquarted in Europe, Pentasweet brings together world-class scientific innovation and industrial scalability to deliver a zero-calorie sugar alternative with no compromise on taste, health or function. Pentasweet produces Brazzein through precision fermentation - a sustainable, scalable method that eliminates reliance on limited wild harvest sources. Our fermentation process enables consistent quality and quantities, and cost efficiency suitable for industrial-scale production.
11 to 50 staff
Ferentis
Ferentis is a research-intensive biotechnology company involved in the development, production and commercialisation of biomimetic peptides and peptide-based scaffolds for tissue engineering and regenerative medicine applications. Ferentis was established in Vilnius, Lithuania, by a group of scientists and entrepreneurs from Canada, Lithuania, Sweden and India. The idea of establishing the company comes from collaborative research of its founders in the development of “smart” biomaterials that can promote regeneration of tissue cells within the patient without any need of long-term immunosuppressive drugs. Our group combines a unique combination of skills, state-of-the-art scientific research and experience in the fields of biomaterials‘ enhanced cell regeneration, medicinal chemistry, peptidomimetics and surface nano technology. Ferentis‘ range of products includes designer mimics of the biologically-active extracellular matrix of the body that serves as scaffolding and glue to keep the body intact, as well as provides the instructions for repair and regeneration of tissues and organs. Ferentis’ goal is to supply these in form of coatings and kits for in vitro systems. We will also assist our clients in custom-design of biomimetic materials as templates for stimulating regeneration of target tissues and organs for potential clinical application. Our customers are scientific institutions, biopharma and the consumer products industry, who are working in the field of cell research, regenerative medicine, testing and production of drugs, cosmetic and other bioactive products
1 to 10 staff
Fitoterra
Our aspiration is to change people's quality of life, so we are united by mutual trust and cooperation. We are open to new challenges and can offer the possibility of cooperation in further phases of new product development. Since we work only with professionals in our field, we ensure the highest quality and exclusivity as well as innovative solutions. Be a part of scientific progress. Spirulina (lat. Algae Platensis) is chosen based on its properties, not only in terms of ingredients, but also the fact that the oxygen released during photosynthesis by these algae makes up about 73-87% of the total oxygen released in the world. Algae is designated as an "environmentally friendly" raw material, and the production technology is strictly regulated and does not have a negative impact on the environment and conserves natural resources. Modern scientific research principles of plant materials are used in the production, the uniqueness of which is the Open Cell spirulina raw material that forms the basis and the cell disruption production technology. Due to the unique cell disruption technology and manufacturing solutions, the products are definitely given exclusivity and advantage in the market. Open Cell technology enables the direct extraction and use of the entire composition of spirulina (lat. Algae Platensis) cells without damaging or destroying the active substances in the cell. Using the existing technology of free cell components, the spirulina membrane is broken down in a non-mechanical and non-chemical way, as a result of which the substances in the cell are prepared for their more effective penetration.
1 to 10 staff
Kurana
UAB “Kurana” is the first company inside EU which connected manufacturing of bioethanol (base of biofuels), electricity and thermal energy from renewable energy sources (biogas produced by mesocphilic process) into one uninterrupted technological loop. This technological loop produces zero waste plus valuable organic fertilizers that are becoming more and more popular in contemporary farming. When building this factory we used the newest technologies and facilities bought from EU (Germany, Denmark, Sweden and GB) and US.
51 to 200 staff
Uab Mestilla
UAB Mestilla is a biotechnology company based out of Lypkių g, Klaipėda, Klaipėda County, Lithuania.
1 to 10 staff
Fungi Spells
- Biohack your way to vitality!"Nature alone is antique, and the oldest art a mushroom"- Thomas Carlyle Cordyceps for Energy Chaga for Balance Lion's Mane for Focus Reishi for Relax 100% organic and locally grown healthy mushroom extracts.
1 to 10 staff
Keli Therapeutics
KELI Therapeutics is a clinical-stage biotech university spin-out company specializing in cell-based therapeutics. Seeking Visionary Investors: We are currently raising 5 Mio EUR (24 months of the runway) to accelerate our lead program, KELI-101, in a First-In-Human, multi-center, adaptive Ph1/2A-B clinical trial (24 months) Pioneering Allogeneic GMP-grade Placental Stem Cells: Backed by non-dilutive funding, our proprietary platform has undergone rigorous validation in four non-clinical animal studies, setting new benchmarks for therapeutic potential. 🧪 Expert Team of Biotech Innovators: Our interdisciplinary team boasts top-tier drug developers, regulatory experts, biotechnologists, and physicians, united in delivering groundbreaking medical breakthroughs. Scalable Manufacturing Excellence: Our placental stromal cell-based 2D/3D manufacturing platform ensures streamlined production of an extensive pipeline of advanced therapeutic medicinal products. Quality Control at the Core: Focusing on rigorous quality control measures, we underscore the safety and efficacy of our innovative therapeutic solutions. Collaborate for Success: Seeking partnerships with like-minded investors and biotech pioneers to drive healthcare innovation forward. Investment Opportunities: Join our transformative journey and explore potential significant returns on investment in the rapidly evolving biotech landscape. Global Impact, Local Focus: Embrace the future of medicine as we bridge the gap between scientific advancements and patient-centric solutions with a global reach.
1 to 10 staff
Vugene
At VUGENE we offer bioinformatics data science as a service. Our team is comprised of specialists in biomedical research, bioinformatics, machine learning and software engineering. Our services are tailored for research laboratories studying the origins, causes, treatments and diagnostics of various complex disorders, such as cancers or neurodegenerative disorders. Collective expertise at VUGENE enables efficient management of large datasets resulting from multi-omics experiments. We perform quality control, processing of raw experimental data, normalization, statistical analysis and training of soffisticated machine learning models. We use the latest agile software development techniques to coordinate and streamline our research processes and to write software code that leads to reproducible and publishable results.
1 to 10 staff
